- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RAD001
Total 461 results
-
Revance Therapeutics, Inc.CompletedLateral Canthal LinesUnited States
-
Celularity IncorporatedCelgene CorporationCompleted
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Not yet recruitingAdvanced and Metastatic Solid TumorChina
-
Novartis PharmaceuticalsTerminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedPancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Emory UniversityTerminated
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Neurocrine BiosciencesOregon Health and Science University; University of California, San Francisco; Veristat, Inc... and other collaboratorsCompletedParkinson's DiseaseUnited States
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
University of California, San FranciscoNovartisCompleted
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
University of California, DavisNovartisCompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
Affiris AGCompletedAlzheimer's DiseaseAustria
-
Celularity IncorporatedCompleted
-
M.D. Anderson Cancer CenterCompleted
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.TerminatedIntracranial MeningiomaUnited States
-
University of California, San FranciscoGenentech, Inc.; Novartis Pharmaceuticals; The V Foundation for Cancer ResearchTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedHEAD & NECK CancerUnited States
-
Federico II UniversityCompletedMedullary Thyroid CancerItaly
-
Herbert HurwitzGenentech, Inc.; Novartis PharmaceuticalsCompletedColorectal AdenocarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Yale UniversityNovartisCompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterNovartis; Genentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Myelofibrosis | Mantle Cell LymphomaUnited States
-
University of California, San FranciscoNovartisTerminatedLow Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed OligoastrocytomasUnited States
-
The Methodist Hospital Research InstituteNovartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States
-
RenovoCompletedCicatrixUnited Kingdom
-
Alector Inc.CompletedHealthy | Frontotemporal DementiaUnited States, Canada, United Kingdom
-
Retrotope, Inc.CompletedFriedreich's AtaxiaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedSystemic MastocytosisUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Novartis PharmaceuticalsRecruiting
-
University of Texas Southwestern Medical CenterCompletedRecurrent Childhood EpendymomaUnited States
-
Emory UniversityNovartis; CelgeneCompletedNeuroendocrine Tumors | Solid Organ Malignancies | Adenoidcystic CarcinomaUnited States
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedKidney CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
Shengzhen Sciprogen Bio-pharmaceutical Co. LtdCompleted
-
Retrotope, Inc.CompletedFriedreich's AtaxiaUnited States
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.Active, not recruitingHepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States
-
Novartis PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, Belgium, Taiwan, Turkey, Australia, Korea, Republic of, Thailand, France, Hungary, United Kingdom, Italy, Japan, Canada, Russian Federation, Poland, Mexico, Colombia
-
SCRI Development Innovations, LLCBayer; NovartisCompletedKidney CancerUnited States
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.Completed
-
Sandy SrinivasNovartis; Genentech, Inc.TerminatedKidney Neoplasms | Kidney (Renal Cell) CancerUnited States